Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
nemvaleukin alfa (ALKS 4230)
i
Other names:
RDB1419, ALKS 4230, RDB 1419, ALKS-4230, RDB 1450, RDB-1419, ALKS4230, RDB1450, RDB-1450
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Mural Oncology
Drug class:
IL-2R agonist
Related drugs:
‹
NL-201 (0)
darleukin/fibromun (0)
EMD 521873 (0)
TNRX-257 (0)
RG6279 (0)
TransCon IL-2 β/γ (0)
NL-201 (0)
darleukin/fibromun (0)
EMD 521873 (0)
TNRX-257 (0)
RG6279 (0)
TransCon IL-2 β/γ (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Mucosal Melanoma
No biomarker
Mucosal Melanoma
ALKS 4230
Sensitive: B - Late Trials
ALKS 4230
Sensitive
:
B
ALKS 4230
Sensitive: B - Late Trials
ALKS 4230
Sensitive
:
B
No biomarker
Ovarian Cancer
No biomarker
Ovarian Cancer
pembrolizumab + ALKS 4230
Sensitive: B - Late Trials
pembrolizumab + ALKS 4230
Sensitive
:
B
pembrolizumab + ALKS 4230
Sensitive: B - Late Trials
pembrolizumab + ALKS 4230
Sensitive
:
B
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login